Benchmark Capital Advisors’s Sanofi SNY Stock Holding History

Benchmark Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$386K	Sell	8,900 -400	-4%	-$17.6K	0.38%	63
2018 Q3	$415K	Hold	9,300	–	–	0.31%	71
2018 Q2	$372K	Sell	9,300 -1,200	-11%	-$47.2K	0.28%	85
2018 Q1	$421K	Hold	10,500	–	–	0.33%	78
2017 Q4	$451K	Sell	10,500 -1,100	-9%	-$50.7K	0.35%	75
2017 Q3	$578K	Sell	11,600 -400	-3%	-$19.4K	0.45%	62
2017 Q2	$575K	Sell	12,000 -300	-2%	-$14.3K	0.45%	58
2017 Q1	$557K	Sell	12,300 -700	-5%	-$29.7K	0.44%	57
2016 Q4	$526K	Sell	13,000 -150	-1%	-$5.91K	0.44%	56
2016 Q3	$502K	Sell	13,150 -450	-3%	-$18.1K	0.38%	69
2016 Q2	$569K	Sell	13,600 -200	-1%	-$8.2K	0.46%	61
2016 Q1	$554K	Sell	13,800 -250	-2%	-$10K	0.49%	59
2015 Q4	$599K	Sell	14,050 -700	-5%	-$32.2K	0.51%	58
2015 Q3	$700K	Hold	14,750	–	–	0.57%	53
2015 Q2	$731K	Sell	14,750 -250	-2%	-$12.7K	0.51%	56
2015 Q1	$742K	Buy	+15,000	New	+$717K	0.49%	56

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Benchmark Capital Advisors's SNY Position: Q4 2018 in Review

Benchmark Capital Advisors reduced its Sanofi (SNY) stake by 4.3% in Q4 2018, selling an estimated $17.6K and leaving 8,900 shares worth $386K. The position accounts for 0.38% of the portfolio, ranked #63.

Benchmark Capital Advisors first reported a position in SNY in Q1 2015 and has held it in 16 quarters since. The position peaked at $742K in Q1 2015. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

Benchmark Capital Advisors held 8,900 shares of Sanofi worth $386K as of Q4 2018.
Benchmark Capital Advisors sold 400 Sanofi shares in Q4 2018, an estimated $17.6K.
Sanofi made up 0.38% of Benchmark Capital Advisors's portfolio in Q4 2018, its #63 holding.
Benchmark Capital Advisors first reported a position in Sanofi in Q1 2015 and has held it in 16 quarters since.
Benchmark Capital Advisors's Sanofi position peaked at $742K in Q1 2015.
501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on Benchmark Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.